Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.

Name: Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
License: Public Domain

Swiss Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

b-cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353293
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.